Find a TenderAwarded
Published 20 Jan 2025, 12:02 GMT

Official UK procurement notice

Supply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical Trial: "Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision"

Official notice

Authority: NHS Wales Shared Services Partnership (NWSSP) - Procurement Services (NHS & healthcare)

GoodsNegotiated without publication of a contract notice
Awarded value£116,645published contract · exc. VAT
Awarded 1 Jan 2025
Awarded to SIMBEC RESEARCH LIMITED

What is being bought

Published requirement description

Cardiff and Vale University Health Board (CAVUHB) is undertaking a clinical trial entitled ‘Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision’, funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment Programme (Ref: NIHR 160872). As part of this clinical trial, an Investigational Medicinal Product (IMP) needs to be manufactured and distributed.

CPV: Medical equipments, pharmaceuticals and personal care products

The lotProcurement structure

single lot · no lot value published
Lot #1Supply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical…

Supply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical Trial: "Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision"

Cardiff and Vale University Health Board (CAVUHB) is undertaking a clinical trial entitled ‘Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision’, funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment Programme (Ref: NIHR 160872). As part of this clinical trial, an Investigational Medicinal Product (IMP) needs to be manufactured and distributed. The IMPs required are:

-Flucloxacillin 2 x 500mg capsules, over encapsulated

-A matching placebo of inert filler, over encapsulated to match flucloxacillin 2 x 500mg capsules.

The successful supplier will be responsible for the manufacture, packaging, labelling, Quality Assurance (QA) certification, storage, shipment, and regulatory compliance (CTIMP regulations) associated with the trial’s IMPs.

After extensive market research and consultations with multiple suppliers, it has been concluded that only one supplier, Simbec-Orion, has the capability to fulfil the full scope of the contract requirements. This includes:

-Over encapsulation of flucloxacillin and matching placebo

-Packaging and labelling of the final product

-Compliance with clinical trial regulations (CTIMP)

-Storage and shipment logistics to participating NHS sites

-QA certification and regulatory compliance for blinded clinical trials

Simbec-Orion will also source the bulk IMP (4 lots of flucloxacillin, 1 lot of placebos), over encapsulate the product, and ensure all necessary documentation and quality assurance procedures are met.

Simbec-Orion is uniquely positioned to meet the requirements of the clinical trial due to its established capabilities in the manufacture and regulatory compliance of Investigational Medicinal Products (IMPs). No other supplier was found to be able to offer the complete set of services required for this project.

Delivery: Wales

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Negotiated without publication of a contract notice
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
20 Jan 2025, 12:02 GMT
Last source update
20 Jan 2025, 12:02 GMT
FTS notice number
2025/S 000-001841
Classification (CPV)
Medical equipments, pharmaceuticals and personal care products
Delivery area
Wales (UKL22)
Official registry OCID
ocds-h6vhtk-04d494 Find a Tender
Why no open competition

The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the directive

Published justification

The products involved are manufactured purely for the purpose of research. In addition, Simbec-Orion is positioned to meet the requirements of the clinical trial. No other supplier was found to be able to offer the complete set of services required for this project.

Publisher note: NHS Wales Shared Services Partnership are publishing this notice on behalf of; Cardiff and Vale University Health Board Woodland House Maes-y-Coed Road Cardiff CF14 4HH A standstill period of 10 calendar days from publication of this notice will be observed by the authority prior to entering into a contract. NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=147495. (WA Ref:147495)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £116,6451 contract exc. VAT
Contracts signed 1latest 1 Jan 2025
Awarded toValueDateStatus
SIMBEC RESEARCH LIMITEDSME£116,645 †—Awarded

Contracts

Contracting authority & participating public bodies

NHS Wales Shared Services Partnership (NWSSP) - Procurement Services

Contracting authorityNHS & healthcareBody governed by public lawHealth Woodland House, 2nd Floor, Maes-Y-Coed Road, Cardiff, UK, CF14 4HHContact name, email, phone

Dispute resolution & review bodies

  • High CourtReview body LondonContact phone

Bidders & participating suppliers

1 commercial party on the notice
  • SIMBEC RESEARCH LIMITEDAwarded supplier Simbec House Merthyr Tydfil Industrial Park, Pentrebach, Merthyr Tydfil, Wales, CF484DRContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.